SILO
Silo Pharma, Inc.
There isn't enough reported data to score SILO yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SILO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
SILO's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SILO PE Valuation
SILO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SILO Forward outlook
There aren't enough analyst estimates for SILO to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SILO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$13.80 | +$4.07 |
| Q2 2025 | -$15.30 | +$2.42 |
| Q1 2025 | -$17.10 | +$0.77 |
| Q4 2024 | -$17.85 | +$0.17 |
| Q3 2024 | -$17.87 | +$12.45 |
| Q2 2024 | -$17.72 | +$16.80 |
| Q1 2024 | -$17.87 | +$19.35 |
| Q4 2023 | -$18.02 | +$14.85 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 177% for SILO versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
SILO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $18K | 0% |
| Q4 2025 | $18K | 0% |
| Q3 2025 | $18K | 0% |
| Q2 2025 | $18K | 0% |
| Q1 2025 | $18K | 0% |
| Q4 2024 | $18K | 0% |
| Q3 2024 | $18K | 0% |
| Q2 2024 | $18K | 0% |
SILO's revenue has slid since its 2021 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -8846% | -2777 points |
| Q4 2025 | -4363% | +5696 points |
| Q3 2025 | -6388% | -785 points |
| Q2 2025 | -6927% | -1364 points |
| Q1 2025 | -6070% | -1191 points |
| Q4 2024 | -10060% | -3604 points |
| Q3 2024 | -5604% | -1313 points |
| Q2 2024 | -5563% | +623 points |
SILO's operating margin was −8846% last quarter, down 2777 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over SILO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
SILO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$781.9K | +$503.4K |
| Q1 2026 | -$822.6K | +$817.7K |
| Q4 2025 | -$780.3K | +$137.2K |
| Q3 2025 | -$955.5K | +$391K |
| Q2 2025 | -$1.3M | -$553.5K |
| Q1 2025 | -$1.6M | -$802.1K |
| Q4 2024 | -$917.4K | -$7.4K |
| Q3 2024 | -$1.3M | -$274.7K |
SILO has burned cash in almost every quarter: −$3M over the past year, against −$5M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SILO on cash generation, producing positive trailing cash flow while its opponent burns cash.
SILO Net Leverage
SILO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SILO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.7 | Neutral |
| Stochastic | 12.9 | Oversold |
SILO's weekly RSI is 35 (neutral) and its Stochastic is 13 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SILO PE vs Healthcare Sector
| Metric | SILO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SILO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SILO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.44 | 33% above |
| 20 week MA | $2.77 | 31% below |
| 50 week MA | $4.58 | 58% below |
| 100 week MA | $8.91 | 79% below |
| 200 week MA | $17.4 | 89% below |
SILO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 89% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SILO on trend strength, trading above more of its moving averages.
SILO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $262.5 | $101.3 | -61% |
| 2022 | $101.3 | $45.0 | -56% |
| 2023 | $45.0 | $21.6 | -52% |
| 2024 | $21.6 | $14.1 | -35% |
| 2025 | $14.1 | $5.47 | -61% |
| 2026 YTD | $5.47 | $1.91 | -65% |
SILO has finished every year since 2021 lower, and it's down 65% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SILO on returns for 2026, with the stronger performance.